Annual Working Capital
$238.62 M
+$133.88 M+127.81%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual working capital is $238.62 million, with the most recent change of +$133.88 million (+127.81%) on December 31, 2023.
- During the last 3 years, MLYS annual working capital has risen by +$242.24 million (+6697.21%).
- MLYS annual working capital is now at all-time high.
Performance
MLYS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$236.41 M
-$53.19 M-18.37%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly working capital is $236.41 million, with the most recent change of -$53.19 million (-18.37%) on September 30, 2024.
- Over the past year, MLYS quarterly working capital has dropped by -$2.21 million (-0.93%).
- MLYS quarterly working capital is now -27.84% below its all-time high of $327.62 million, reached on March 31, 2024.
Performance
MLYS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MLYS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.8% | -0.9% |
| 3 y3 years | +6697.2% | -10.2% |
| 5 y5 years | +6697.2% | -10.2% |
MLYS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3832.4% | -27.8% | +3796.0% |
| 5 y | 5-year | at high | +6697.2% | -27.8% | +3796.0% |
| alltime | all time | at high | +6697.2% | -27.8% | +3796.0% |
Mineralys Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $236.41 M(-18.4%) |
| Jun 2024 | - | $289.60 M(-11.6%) |
| Mar 2024 | - | $327.62 M(+37.3%) |
| Dec 2023 | $238.62 M | $238.62 M(-5.2%) |
| Sep 2023 | - | $251.83 M(-4.3%) |
| Jun 2023 | - | $263.28 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $264.71 M(+152.7%) |
| Dec 2022 | $104.74 M(+1626.2%) | $104.74 M(-8.7%) |
| Sep 2022 | - | $114.67 M(+1789.7%) |
| Dec 2021 | $6.07 M(-267.8%) | - |
| Dec 2021 | - | $6.07 M |
| Dec 2020 | -$3.62 M | - |
FAQ
- What is Mineralys Therapeutics annual working capital?
- What is the all time high annual working capital for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual working capital year-on-year change?
- What is Mineralys Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly working capital year-on-year change?
What is Mineralys Therapeutics annual working capital?
The current annual working capital of MLYS is $238.62 M
What is the all time high annual working capital for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual working capital is $238.62 M
What is Mineralys Therapeutics annual working capital year-on-year change?
Over the past year, MLYS annual working capital has changed by +$133.88 M (+127.81%)
What is Mineralys Therapeutics quarterly working capital?
The current quarterly working capital of MLYS is $236.41 M
What is the all time high quarterly working capital for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly working capital is $327.62 M
What is Mineralys Therapeutics quarterly working capital year-on-year change?
Over the past year, MLYS quarterly working capital has changed by -$2.21 M (-0.93%)